CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Rising prevalence of target diseases
4.1.2. Growing focus on providing public-access defibrillators
4.1.3. Technological advancements in defibrillators
4.1.4. Training & awareness programs on defibrillators
4.1.5. Development of S-ICDS and MRI-compatible ICDS & CRT-Ds
4.2. Market Restraints & Challenges
4.2.1. Lack of awareness about the sudden cardiac arrest
4.2.2. Frequent product recalls
4.2.3. Issues related to the use of implantable and automated external defibrillators
CHAPTER 5. GLOBAL DEFIBRILLATORS MARKET – BY PRODUCT
5.1. External Defibrillators
5.1.1. Manual External Defibrillators
5.1.2. Wearable Cardioverter Defibrillators
5.1.3. Automated External Defibrillators
5.1.3.1. Fully Automated External Defibrillators
5.1.3.2. Semi-Automated External Defibrillators
5.2. Implantable Cardioverter Defibrillators
5.2.1. Subcutaneous Implantable Cardioverter Defibrillators
5.2.2. Transvenous Implantable Cardioverter Defibrillators
5.2.2.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators
5.2.2.2. Dual-Chamber ICDS
5.2.2.3. Single-Chamber ICDS
CHAPTER 6. GLOBAL DEFIBRILLATORS MARKET – BY END USER
6.1. Public Access Markets
6.2. Home Care Settings
6.3 Alternate Care Facilities
6.4. Hospitals, Clinics, and Cardiac Centers
6.5. Pre-Hospital Care Settings
6.6. Others
CHAPTER 7. GLOBAL DEFIBRILLATORS MARKET – BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.8. Switzerland
7.4.9. Poland
7.4.10. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8. GLOBAL DEFIBRILLATORS MARKET - COMPANY PROFILES
8.1. Cardiac Science Corporation
8.2. Nihon Kohden Corporation
8.3. HeartSine Technologies LLC.
8.4. GE Healthcare Co., Ltd.
8.5. koninklijke Philips N.V.
8.6. ZOLL Medical Corporation
8.7. Mindray Medical International Limited
8.8. Defibtech, LLC.
8.9. Physio-Control, Inc.
8.10. Schiller AG
8.11. Mindray Bio-Medical Electronics Co., Ltd.
8.12. Metrax GmbH
8.13. St. Jude Medical, Inc.
8.14. Livanova PLC
8.15. Boston Scientific Corporation
CHAPTER 9. GLOBAL DEFIBRILLATORS MARKET – COMPETITIVE
LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
